| Literature DB >> 30310878 |
Ju-Hee Lee1, Jae-Hyeong Park2.
Abstract
Right ventricular (RV) systolic dysfunction has been identified as an independent prognostic marker of many cardiovascular diseases. However, there are problems in measuring RV systolic function objectively and identification of RV dysfunction using conventional echocardiography. Strain echocardiography is a new imaging modality to measure myocardial deformation. It can measure intrinsic myocardial function and has been used to measure regional and global left ventricular (LV) function. Although the RV has different morphologic characteristics than the LV, strain analysis of the RV is feasible. After strain echocardiography was introduced to measure RV systolic function, it became more popular and was incorporated into recent echocardiographic guidelines. Recent studies showed that RV global longitudinal strain (RVGLS) can be used as an objective index of RV systolic function with prognostic significance. In this review, we discuss RVGLS measurement, normal reference values, and the clinical importance of RVGLS.Entities:
Keywords: Prognosis; Right ventricle; Strain echocardiography; Systolic function
Year: 2018 PMID: 30310878 PMCID: PMC6160817 DOI: 10.4250/jcvi.2018.26.e11
Source DB: PubMed Journal: J Cardiovasc Imaging
Figure 1(A) Measurement of right ventricular (RV) systolic function with conventional echocardiographic method: RV fractional area change is calculated from the division of the subtraction of the RV end-systolic area (RVESA) to the RV end-diastolic area (RVEDA) by RVEDA. (B) Tricuspid annular systolic excursion (TAPSE) is the distance between end-diastolic and peak systolic points of the lateral tricuspid annulus. (C) Tricuspid annular S’ velocity can be measured by tissue Doppler application of the lateral tricuspid annulus. (D) The RV Tei index can be measured conventionally by pulsed Doppler [(tricuspid valve closure to opening time (TCO) − ejection time of pulmonic valve (PVET)) / PVET] or the tissue Doppler method [(isovolumic contraction time (ICT) + isovolumic relaxation time (IVRT)) / ejection time (ET)] from the tricuspid annulus.
Figure 2Demonstration of right ventricular strain measurement by GE EchoPAC software (A) and velocity vector imaging (B).
Normal reference values for right ventricular global longitudinal strain according to sex, age, and vendors
| Parameter | First author | Normal range | N | Vendor | |
|---|---|---|---|---|---|
| Women (mean±SD) | Men (mean±SD) | ||||
| RVGLStotal (%) | Muraru et al. | −26.7 ± 3.1 | −24.7 ± 2.6 | 276 | GE EchoPAC |
| RVGLStotal (%) | Park et al. | < 30 years old: −22.8 ± 2.5 | < 30 years old: −20.8 ± 2.9 | 493 | GE EchoPAC |
| 31–40 years old: −23.2 ± 3.6 | 31–40 years old: −20.1 ± 2.5 | ||||
| 41–50 years old: −22.5 ± 3.1 | 41–50 years old: −20.4 ± 3.0 | ||||
| 51–60 years old: −21.8 ± 3.1 | 51–60 years old: −21.0 ± 3.3 | ||||
| > 60 years old: −21.3 ± 3.7 | > 60 years old: −21.0 ± 3.0 | ||||
| RVGLStotal (%) | Meris et al. | −24.2 ± 2.9 | 100 | GE EchoPAC | |
| RVGLSfree wall (%) | Muraru et al. | −31.6 ± 4.0 | −29.3 ± 3.4 | 276 | GE EchoPAC |
| RVGLSfree wall (%) | Park et al. | < 30 years old: −28.2 ± 3.8 | < 30 years old: −25.8 ± 3.7 | 493 | GE EchoPAC |
| 31–40 years old: −28.5 ± 4.7 | 31–40 years old: −24.7 ± 3.5 | ||||
| 41–50 years old: −27.3 ± 4.0 | 41–50 years old: −25.3 ± 3.6 | ||||
| 51–60 years old: −27.1 ± 4.2 | 51–60 years old: −25.9 ± 4.2 | ||||
| > 60 years old: −25.2 ± 4.9 | > 60 years old: −26.1 ± 3.8 | ||||
| RVGLSfree wall (%) | Meris et al. | −28.7 ± 4.1 | 100 | GE EchoPAC | |
| RVGLSfree wall (%) | Fine et al. | −26.0 ± 4.0 | 116 | GE EchoPAC | |
| RVGLSfree wall (%) | Fine et al. | −21.7 ± 4.2 | 209 | VVI | |
RVGLS: right ventricular global longitudinal strain, SD: standard deviation, VVI: velocity vector imaging.
Studies showing prognostic significance of right ventricular strain values in different patient population
| First author | Design | N | Population | Outcome | Cutoff (%) | Size of effect or test performance | Analysis software |
|---|---|---|---|---|---|---|---|
| Motoji et al. | Retrospective | 42 | PAH | Cardiovascular events | RVGLSfree wall: −19.4% | N/A | GE EchoPAC |
| Choi et al. | Retrospective | 51 | PAH | Event-free survival and mortality | RVGLStotal: −15.5% | Event-free survival (HR = 4.91, p = 0.001) | VVI |
| Mortality (HR = 8.84, p = 0.005) | |||||||
| Fine et al. | Prospective | 575 | PH | Mortality | Mortality per 6.7% decrease (HR = 2.59, p < 0.001, univariate, HR = 1.46, p < 0.001, multivariate) | GE EchoPAC | |
| D'Andrea et al. | Retrospective | 100 | PH from IPF | Event-free survival | RVGLStotal: −12.0% | Event-free survival (HR = 4.7, p < 0.001) | Philips |
| Grant et al. | Retrospective | 117 | Advanced HF | RV failure | RVGLStotal: −9.6% | N/A | VVI |
| Park et al. | Retrospective | 57 | ICM | Event-free survival | RVGLStotal: −15.4% | Event-free survival (HR = 3.95, p = 0.044) | VVI |
| Park et al. | Retrospective | 282 | Inferior AMI | Event-free survival and mortality | RVGLStotal: −15.5% | N/A | VVI |
AMI: acute myocardial infarction, HF: heart failure, HR: hazard ratio, ICM: ischemic cardiomyopathy, IPF: idiopathic pulmonary fibrosis, PAH: pulmonary arterial hypertension, PH: pulmonary hypertension, RVGLS: right ventricular global longitudinal strain, VVI: velocity vector imaging.